Opinion|Videos|September 6, 2024

Key Factors to Consider when Switching to Biosimilars

Dr Humphreys discusses key factors to consider when switching to biosimilars.

Video content above is prompted by the following:

  • To what extent should the pharmacy team prioritize supporting the switch from a reference product to a biosimilar, and what factors should be considered in making this decision?

Latest CME